세계의 심장학 및 신경학 체외진단(IVD) 시장 보고서(2025년)

In vitro diagnostic (IVD) in cardiology and neurology involves conducting medical tests on samples such as blood, urine, or tissue outside the body to diagnose a range of cardiovascular and neurological ailments. These tests are pivotal for detecting conditions such as heart disease, stroke, Alzheimer's disease, and more, aiding in early diagnosis, ongoing monitoring, and treatment planning. They offer timely diagnostic insights crucial for guiding patient care and enhancing outcomes in both cardiology and neurology.

The main products of in vitro diagnostic (IVD) in cardiology and neurology encompass instruments, reagents and consumables, and software and services. Instruments denote the tools or apparatuses utilized for conducting diagnostic examinations and scrutinizing patient specimens within laboratory environments. These encompass various technologies such as immunoassays, molecular diagnostics, and hematology, catering to the needs of hospitals, clinical laboratories, and similar entities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The in vitro diagnostic (IVD) in cardiology and neurology market research report is one of a series of new reports from The Business Research Company that provides in vitro diagnostic (IVD) in cardiology and neurology market statistics, including the in vitro diagnostic (IVD) in cardiology and neurology industry global market size, regional shares, competitors with in vitro diagnostic (IVD) in cardiology and neurology market share, detailed in vitro diagnostic (IVD) in cardiology and neurology market segments, market trends, and opportunities, and any further data you may need to thrive in the in vitro diagnostic (IVD) in cardiology and neurology industry. This in vitro diagnostic (IVD) in cardiology and neurology market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The in vitro diagnostic (ivd) in cardiology and neurology market size has grown strongly in recent years. It will grow from $15.84 billion in 2024 to $17.22 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to rise in the prevalence of age-related cardiovascular and neurological disorders, rise in the aging population, growing emphasis on preventive healthcare and early disease detection, the increasing burden of cardiovascular diseases (CVDs) and neurological disorders, such as stroke and Alzheimer's disease, rise in investments in healthcare infrastructure, and rise in supportive regulatory frameworks governing the approval and reimbursement of diagnostic tests.

The in vitro diagnostic (ivd) in cardiology and neurology market size is expected to see strong growth in the next few years. It will grow to $23.59 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to the shift towards personalized medicine in cardiology and neurology, increasing demand for rapid and on-site testing solutions in cardiology and neurology, expansion of telemedicine and remote consultation services, and rise in research initiatives. Major trends in the forecast period include emergence of liquid biopsy technologies, advancements in nanotechnology, adoption of remote monitoring devices, such as implantable cardiac monitors and brain-computer interfaces, use of multiplex biomarker panels, innovations in medical imaging modalities, such as MRI, CT, and PET scans, and development of companion diagnostics for cardiovascular and neurological drugs.

The forecast of 8.2% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. adoption of rapid troponin and amyloid beta tests by inflating prices of IVD assays developed in Sweden and Belgium, resulting in delayed stroke and heart attack diagnoses and higher emergency care costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The expansion of personalized medicine is poised to drive the advancement of the in vitro diagnostic (IVD) market in cardiology and neurology in the foreseeable future. Personalized medicine, which customizes healthcare interventions and treatments to suit the unique characteristics of individual patients, is gaining momentum due to progress in genomics, enhanced understanding of disease mechanisms, patient demand for tailored therapies, and regulatory backing, among other factors. In cardiology and neurology, IVD tests play a pivotal role in facilitating personalized medicine by furnishing essential insights into an individual's genetic composition and disease status. These insights guide the development of customized treatment strategies, thereby enhancing efficacy and minimizing risks. For instance, data from the Personalized Medicine Coalition indicates that in 2022, approximately 34% of all newly approved therapies were personalized medicines, marking a significant rise from previous years. Hence, the escalating adoption of personalized medicines is propelling the growth of the in vitro diagnostic (IVD) market in cardiology and neurology.

Major companies operating in the in vitro diagnostic (IVD) in cardiology and neurology market are innovating AI-driven integrated epigenetic systems to enable early detection of diseases and assess risks. These AI-enabled integrated epigenetic systems utilize machine learning and advanced biomarker analysis methods to improve the precision and sensitivity of diagnosing and monitoring cardiovascular conditions, thereby targeting key factors influencing disease advancement. For example, in February 2023, Cardio Diagnostics Holdings Inc., a US-based biotechnology firm, introduced PrecisionCHD, an AI-powered blood test engineered for the timely identification of coronary heart disease (CHD). Employing the company's integrated epigenetic-genetic engine, this test evaluates CHD susceptibility and strives to preemptively detect the most prevalent cardiovascular ailment. Combining epigenetic and genetic indicators with machine learning algorithms, the new test delivers over 75% sensitivity for both genders. It establishes a connection between a patient's biomarker profile and modifiable risk elements, such as smoking, diabetes, hypertension, and elevated cholesterol levels, which significantly contribute to CHD. PrecisionCHD presents a non-invasive option to conventional methods such as exercise stress tests or angiograms, as it requires blood samples collected either at the clinic or home.

In March 2024, Beckman Coulter, a US-based company specializing in laboratory diagnostics, expanded its partnership with Fujirebio to focus on the development, manufacturing, and clinical adoption of neurodegenerative disease assays. This collaboration aims to combine their expertise in laboratory diagnostics and neurological markers to advance the development of innovative assays for diagnosing neurodegenerative diseases, ultimately improving patient outcomes through more accurate and timely diagnostics. Fujirebio, a Japan-based company, specializes in in vitro diagnostics (IVD) in cardiology and neurology.

Major companies operating in the in vitro diagnostic (IVD) in cardiology and neurology market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Hologic Inc., Illumina Inc., Beckman Coulter Inc., Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Instrumentation Laboratory, bioMerieux SA, Natera, Inc., Randox Laboratories Ltd., Fulgent Genetics Inc., DiaSorin S.p.A., Oxford Nanopore Technologies, Fujirebio Diagnostics Inc., Adaptive Biotechnologies, Biocartis Group NV, Agena Bioscience

North America was the largest region in the in vitro diagnostic (IVD) in cardiology and neurology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vitro diagnostic (IVD) in cardiology and neurology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the in vitro diagnostic (IVD) in cardiology and neurology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The in vitro diagnostic (IVD) in cardiology and neurology market consists of revenues earned by entities by providing services such as point-of-care testing, laboratory testing, molecular diagnostics, and biomarker testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In Vitro Diagnostic (IVD) In Cardiology And Neurology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on in vitro diagnostic (ivd) in cardiology and neurology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in vitro diagnostic (ivd) in cardiology and neurology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The in vitro diagnostic (ivd) in cardiology and neurology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Instruments; Reagents And Consumables; Software And Services
• 2) By Technology: Immunoassays; Molecular Diagnostics; Hematology; Other Technologies
• 3) By End-User: Hospitals; Clinical Laboratories; Other End-Users
• Subsegments:
• 1) By Instruments: Diagnostic Analyzers; Point-Of-Care Devices; Electrophysiology Devices
• 2) By Reagents And Consumables: Diagnostic Reagents; Test Kits; Assay Consumables
• 3) By Software And Services: Diagnostic Software; Data Management Software; IVD Consulting And Support Services
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Becton Dickinson And Company; Quest Diagnostics Incorporated; Hologic Inc.; Illumina Inc.; Beckman Coulter Inc.; Quidel Corporation; Sysmex Corporation; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Instrumentation Laboratory; bioMerieux SA; Natera, Inc.; Randox Laboratories Ltd.; Fulgent Genetics Inc.; DiaSorin S.p.A.; Oxford Nanopore Technologies; Fujirebio Diagnostics Inc.; Adaptive Biotechnologies; Biocartis Group NV; Agena Bioscience
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Characteristics

3. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Trends And Strategies

4. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Growth Analysis And Strategic Analysis Framework

• 5.1. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Growth Rate Analysis
• 5.4. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Total Addressable Market (TAM)

6. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Segmentation

• 6.1. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Instruments
• Reagents And Consumables
• Software And Services
• 6.2. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunoassays
• Molecular Diagnostics
• Hematology
• Other Technologies
• 6.3. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinical Laboratories
• Other End-Users
• 6.4. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Sub-Segmentation Of Instruments: Diagnostic Analyzers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Point-Of-Care Devices
• Electrophysiology Devices
• 6.5. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Reagents
• Test Kits
• Assay Consumables
• 6.6. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Software
• Data Management Software
• IVD Consulting And Support Services

7. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Regional And Country Analysis

• 7.1. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 8.1. Asia-Pacific In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 9.1. China In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
• 9.2. China In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 10.1. India In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 11.1. Japan In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
• 11.2. Japan In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 12.1. Australia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 13.1. Indonesia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 14.1. South Korea In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
• 14.2. South Korea In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 15.1. Western Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
• 15.2. Western Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 16.1. UK In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 17.1. Germany In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 18.1. France In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 19.1. Italy In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 20.1. Spain In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 21.1. Eastern Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
• 21.2. Eastern Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 22.1. Russia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 23.1. North America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
• 23.2. North America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 24.1. USA In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
• 24.2. USA In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 25.1. Canada In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
• 25.2. Canada In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 26.1. South America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
• 26.2. South America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 27.1. Brazil In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 28.1. Middle East In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
• 28.2. Middle East In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

• 29.1. Africa In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
• 29.2. Africa In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Competitive Landscape And Company Profiles

• 30.1. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Competitive Landscape
• 30.2. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Other Major And Innovative Companies

• 31.1. Becton Dickinson And Company
• 31.2. Quest Diagnostics Incorporated
• 31.3. Hologic Inc.
• 31.4. Illumina Inc.
• 31.5. Beckman Coulter Inc.
• 31.6. Quidel Corporation
• 31.7. Sysmex Corporation
• 31.8. Bio-Rad Laboratories Inc.
• 31.9. QIAGEN N.V.
• 31.10. Instrumentation Laboratory
• 31.11. bioMerieux SA
• 31.12. Natera, Inc.
• 31.13. Randox Laboratories Ltd.
• 31.14. Fulgent Genetics Inc.
• 31.15. DiaSorin S.p.A.

32. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

34. Recent Developments In The In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

35. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market High Potential Countries, Segments and Strategies

• 35.1 In Vitro Diagnostic (IVD) In Cardiology And Neurology Market In 2029 - Countries Offering Most New Opportunities
• 35.2 In Vitro Diagnostic (IVD) In Cardiology And Neurology Market In 2029 - Segments Offering Most New Opportunities
• 35.3 In Vitro Diagnostic (IVD) In Cardiology And Neurology Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer